Jundishapur Journal of Microbiology

Published by: Kowsar

Occult Hepatitis B Infection in Hepatitis C Patients with Hematological Disorders

Nematollah Jonaidi-Jafari 1 , Mohammad Saeid Rezaee-Zavareh 2 , 3 , 4 , * , Javad Tavallaei-Nosratabadi 1 , Reza Ajudani 2 , Mahdi Ramezani-Binabaj 2 , Hamidreza Karimi-Sari 2 , 3 , 4 , Morteza Izadi 1 , Reza Ranjbar 5 , Seyyed Mohammad Miri 6 and Seyed Moayed Alavian 3 , 4
Authors Information
1 Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
3 Baqiyatallah Research Center for Gastroenterology and Liver (BRCGL) Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
4 Middle East Liver Diseases Center (MELD), Tehran, IR Iran
5 Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
6 Kowsar Medical Institute, Heerlen, The Netherlands
Article information
  • Jundishapur Journal of Microbiology: February 01, 2017, 10 (2); e40816
  • Published Online: December 26, 2016
  • Article Type: Research Article
  • Received: July 14, 2016
  • Revised: October 30, 2016
  • Accepted: December 21, 2016
  • DOI: 10.5812/jjm.40816

To Cite: Jonaidi-Jafari N, Rezaee-Zavareh M S, Tavallaei-Nosratabadi J, Ajudani R, Ramezani-Binabaj M, et al. Occult Hepatitis B Infection in Hepatitis C Patients with Hematological Disorders, Jundishapur J Microbiol. 2017 ; 10(2):e40816. doi: 10.5812/jjm.40816.

Abstract
Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Kalantari H, Ferdowsi F, Yaran M. Prevalence of occult hepatitis B virus infection in hemodialysis patients in Isfahan, Iran. Adv Biomed Res. 2016; 5: 151[DOI][PubMed]
  • 2. Vaezjalali M, Rashidpour S, Rezaee H, Hajibeigi B, Zeidi M, Gachkar L, et al. Hepatitis B viral DNA among HBs antigen negative healthy blood donors. Hepat Mon. 2013; 13(3)[DOI][PubMed]
  • 3. Asli M, Kandelouei T, Rahimyan K, Davoodbeglou F, Vaezjalali M. Characterization of Occult Hepatitis B Infection Among Injecting Drug Users in Tehran, Iran. Hepat Mon. 2016; 16(3)[DOI][PubMed]
  • 4. Sharifi-Mood B, Sanei-Moghaddam E, Ghasem-Zadeh I, Khosravi S. Occult hepatitis B virus infection among anti-HBc only positive individuals in the Southeast of Iran in high prevalence of HBV infection region. Iran Red Crescent Med J. 2009; 11(1): 90
  • 5. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008; 49(4): 652-7[DOI][PubMed]
  • 6. Ahmad Akhoundi MS, Momeni N, Norouzi M, Ghalichi L, Shamshiri AR, Alavian SM, et al. Prevalence of blood-borne viruses among Iranian dentists: Results of a national survey. Int J Occup Med Environ Health. 2015; 28(3): 593-602[DOI][PubMed]
  • 7. Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Scand J Gastroenterol. 2008; 43(7): 849-56[DOI][PubMed]
  • 8. Shi Y, Wu YH, Wu W, Zhang WJ, Yang J, Chen Z. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis. Liver Int. 2012; 32(2): 231-40[DOI][PubMed]
  • 9. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat. 2002; 9(4): 243-57[PubMed]
  • 10. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002; 2(8): 479-86[PubMed]
  • 11. Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang. 2004; 86(2): 83-91[DOI][PubMed]
  • 12. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med. 1999; 341(1): 22-6[DOI][PubMed]
  • 13. Fukuda R, Ishimura N, Niigaki M, Hamamoto S, Satoh S, Tanaka S, et al. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol. 1999; 58(3): 201-7[PubMed]
  • 14. Mariscal LF, Rodriguez-Inigo E, Bartolome J, Castillo I, Ortiz-Movilla N, Navacerrada C, et al. Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum. J Med Virol. 2004; 73(2): 177-86[DOI][PubMed]
  • 15. Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F. HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease. J Med Virol. 2001; 64(3): 350-5[PubMed]
  • 16. Abu El Makarem MA, Abdel Hamid M, Abdel Aleem A, Ali A, Shatat M, Sayed D, et al. Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection. Hepat Mon. 2012; 12(4): 253-8[DOI][PubMed]
  • 17. Koike K, Nakamura Y, Kobayashi M, Takada S, Urashima T, Saigo K, et al. Hepatitis B virus DNA integration frequently observed in the hepatocellular carcinoma DNA of hepatitis C virus-infected patients. Int J Oncol. 1996; 8(4): 781-4[PubMed]
  • 18. Uchida T, Kaneita Y, Gotoh K, Kanagawa H, Kouyama H, Kawanishi T, et al. Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection. J Med Virol. 1997; 52(4): 399-405[PubMed]
  • 19. Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat. 2010; 17(1): 1-15[DOI][PubMed]
  • 20. Shouval D. What is the clinical significance of the high prevalence of occult hepatitis B in US liver transplant patients with chronic hepatitis C? Liver Transpl. 2008; 14(4): 418-9[DOI][PubMed]
  • 21. Arababadi MK, Hassanshahi G, Yousefi H, Zarandi ER, Moradi M, Mahmoodi M. No detected hepatitis B virus-DNA in thalassemic patients infected by hepatitis C virus in Kerman province of Iran. Pak J Biol Sci. 2008; 11(13): 1738-41[PubMed]
  • 22. Plymoth A, Viviani S, Hainaut P. Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer prevention. Cancer Lett. 2009; 286(1): 15-21[DOI][PubMed]
  • 23. Windyga J, Brojer E, Gronowska A, Grabarczyk P, Mikulska K, Szczepanik AB, et al. Preliminary results of HBV DNA testing of Polish haemophilia patients--lack of occult HBV infection. Haemophilia. 2006; 12(4): 380-3[DOI][PubMed]
  • 24. Toyoda H, Hayashi K, Murakami Y, Honda T, Katano Y, Nakano I, et al. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan. J Med Virol. 2004; 73(2): 195-9[DOI][PubMed]
  • 25. Singh H, Pradhan M, Singh RL, Phadke S, Naik SR, Aggarwal R, et al. High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions. Vox Sang. 2003; 84(4): 292-9[PubMed]
  • 26. Hesamizadeh K, Sharafi H, Rezaee-Zavareh MS, Behnava B, Alavian SM. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepat Mon. 2016; 16(4)[DOI][PubMed]
  • 27. Alizadeh Z, Milani S, Sharifi Z. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study. Arch Iran Med. 2014; 17(2): 106-7[PubMed]
  • 28. Keechilot CS, Shenoy V, Kumar A, Biswas L, Vijayrajratnam S, Dinesh K, et al. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Pathogens Global Health. 2016; 110(7-8): 287-91[DOI]
  • 29. Arababadi MK, Hassanshahi G, Pourfathollah AA, Zarandi ER, Kennedy D. Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities. Hepat Mon. 2011; 11(9): 714-8[DOI][PubMed]
  • 30. Arababadi MK, Nasiri Ahmadabadi B, Yousefi Daredor H, Kennedy D. Epidemiology of occult hepatitis B infection among thalassemic, hemophilia, and hemodialysis patients. Hepat Mon. 2012; 12(5): 315-9[DOI][PubMed]
  • 31. Squadrito G, Cacciola I, Alibrandi A, Pollicino T, Raimondo G. Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C. J Hepatol. 2013; 59(4): 696-700[DOI][PubMed]
  • 32. Borhany M, Shamsi T, Boota S, Ali H, Tahir N, Naz A, et al. Transfusion transmitted infections in patients with hemophilia of Karachi, Pakistan. Clin Appl Thromb Hemost. 2011; 17(6): 651-5[DOI][PubMed]
  • 33. Shaker O, Ahmed A, Abdel Satar I, El Ahl H, Shousha W, Doss W. Occult hepatitis B in Egyptian thalassemic children. J Infect Dev Ctries. 2012; 6(4): 340-6[PubMed]
  • 34. Sabat J, Dwibedi B, Dash L, Kar SK. Occult HBV infection in multi transfused thalassemia patients. Indian J Pediatr. 2015; 82(3): 240-4[DOI][PubMed]
  • 35. Chakrabarti S, Pradhan P, Roy A, Hira M, Bandyopadhyay G, Bhattacharya DK. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products. Indian J Public Health. 2006; 50(1): 43-4[PubMed]
  • 36. Alavian SM. Occult hepatitis B in thalassemia: a need for further study. J Infect Dev Ctries. 2012; 6(8): 650-1[DOI][PubMed]
  • 37. Jang JY, Jeong SW, Cheon SR, Lee SH, Kim SG, Cheon YK, et al. Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients. Korean J Hepatol. 2011; 17(3): 206-12[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments